Skip to main content
SpringerLink
Log in

Influence of the Degree of Control of Diabetes on the Prevention, Postponement and Amelioration of Late Complications

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The relationship between hyperglycaemia and the chronic complications of diabetes has been disputed for many years. Some physicians believe that the evidence that hyperglycaemia is the primary determinant of the chronic complications is convincing; others believe the question remains unsettled. Several types of study provide information. In vitro and in vivo studies demonstrate biochemical alterations induced by hyperglycaemia which could lead to structural changes and diabetic complications. Animal models demonstrate that the complications develop with induction of hyperglycaemia and are ameliorated when blood glucose is returned toward normal. Many uncontrolled clinical studies demonstrate an association between diabetes control and complications but cannot prove causality. Controlled clinical trials have sometimes, but not always, shown functional changes sug-gestive of amelioration of complications with control of hyperglycaemia. A definitive clinical trial has not yet been completed. Pancreas transplantation has the potential of completely normalising blood glucose, but studies to date have been limited by small numbers of patients, the advanced state of complications, and the lack of adequate controls.

On balance, the evidence is highly suggestive that hyperglycaemia is a major determinant of the chronic complications of diabetes. Even if the relationship is established, the risk involved in treatment programmes to achieve near normoglycaemia must be better defined so that potential risk versus benefit can be evaluated in the individual patient when making treatment decisions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Amiel SA, Tamborlan WV, Simonson DC, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. New England Journal of Medicine 316: 1176–1183, 1987

    Article  Google Scholar 

  • Ashikaga T, Borodic G, Sims EAH. Multiple daily insulin injections in the treatment of diabetic retinopathy; the Job study revisited. Diabetes 27: 592–596, 1978

    Article  PubMed  CAS  Google Scholar 

  • Ballard DJ, Melton LJ, Dwyer MS, Trautmann JC, Chu CP, et al. Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota. Diabetes Care 9: 334–342, 1986

    Article  PubMed  CAS  Google Scholar 

  • Barbosa J, Ramsay RC, Knobloch WH, Cantrill HL, Norreen H, et al. Histocompatibility antigen frequencies in diabetic retinopathy. American Journal of Ophthalmology 90: 148–153, 1980

    PubMed  CAS  Google Scholar 

  • Brinchmann-Hansen O, Dahl-Jorgensen J, Hanssen KF, Sandvik L, Oslo Study Group. Effects of intensified insulin treatment on various lesions of diabetic retinopathy. American Journal of Ophthalmology 100: 644–653, 1985

    PubMed  CAS  Google Scholar 

  • Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New England Journal of Medicine 318: 1315–1321, 1988

    Article  PubMed  CAS  Google Scholar 

  • Cahill Jr GF, Etzwiler DD, Freinkel N. Control and diabetes. New England Journal of Medicine 294: 1004–1005, 1976

    Article  PubMed  Google Scholar 

  • Colwell JA. Effect of diabetic control on retinopathy. Diabetes 15: 497–499, 1966

    PubMed  CAS  Google Scholar 

  • Covet C, Genton P, Pointel JP, Louies J, Gross P, et al. The prevalence of retinopathy is similar in diabetes mellitus secondary to chronic pancreatitis with or without pancreatectomy and in idiopathic diabetes mellitus. Diabetes Care 8: 323–328, 1985

    Article  Google Scholar 

  • Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, et al. Effect of near normoglycemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo Study. British Medical Journal 293: 1195–1199, 1986

    Article  PubMed  CAS  Google Scholar 

  • Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes O, et al. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo Study. British Medical Journal 290: 811–815, 1985

    Article  PubMed  CAS  Google Scholar 

  • DCCT Research Group. The diabetes control and complications trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes 35: 530–545, 1986

    Article  Google Scholar 

  • DCCT Research Group. Diabetes control and complications trial (DCCT): results of feasibility study. Diabetes Care 10: 1–19, 1987

    Article  Google Scholar 

  • DCCT Research Group. Sounding board: are continuing studies of metabolic control and microvascular complications in insulin-dependent diabetes mellitus justified? New England Journal of Medicine 318: 246–250, 1988

    Article  Google Scholar 

  • Dieb LC, Williams PE. Surveillance in Florida of continuous subcutaneous insulin infusion use in cohort. Diabetes Care 9: 591–595, 1986

    Article  Google Scholar 

  • Dyck PJ, Zimmerman BR, Vilen TH, Minnerath SR, Karnes JL, et al. Nerve glucose, fructose, sorbitol, myo-inositol and fiber degeneration and regeneration in diabetic neuropathy. New England Journal of Medicine 319: 542–547, 1988

    Article  PubMed  CAS  Google Scholar 

  • Engerman RL, Bloodworth JMB, Nelson S. Relationship of microvascular disease in diabetes to metabolic control. Diabetes 26: 760–769, 1977

    Article  PubMed  CAS  Google Scholar 

  • Engerman RL, Kern TS. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36: 808–812, 1987

    Article  PubMed  CAS  Google Scholar 

  • Feldt-Rasmussen B, Mathieson ER, Deckert T. Effect of two years of strict metabolic control on incipient nephropathy in insulin-dependent diabetes. Lancet 2: 1300–1304, 1986a

    Article  PubMed  CAS  Google Scholar 

  • Feldt-Rasmussen B, Mathieson ER, Hegediis L, Deckert T. Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy. New England Journal of Medicine 314: 665–670, 1986b

    Article  PubMed  CAS  Google Scholar 

  • Goldner MG, Knatterud GL, Prout TE. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. III. Clinical implications of UGDP results. Journal of the American Medical Association 218: 1400–1410, 1971

    Article  PubMed  CAS  Google Scholar 

  • Greene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. New England Journal of Medicine 316: 599–606, 1987

    Article  PubMed  CAS  Google Scholar 

  • Guinn TS, Bailey GJ, Mecklenburg RS. Factors related to dis-continuation of continuous subcutaneous insulin-infusion therapy. Diabetes Care 11: 46–51, 1988

    Article  PubMed  CAS  Google Scholar 

  • Hanssen KF, Dahl-Jorgensen K, Brinchmann-Hansen O, Ganes T, Bjoro T, et al. Near normoglycemia for four years improves early diabetic retinopathy, neuropathy and nephropathy — the Oslo study. Highlights on Endocrinology, Proceedings of the First European Congress on Endocrinology, pp. 187–191, Ruis Eds, Norhaven, Bogtnykkere A/8, 1987

  • Hanssen KF, Dahl-Jorgensen K, Lauritzen T, Feldt-Rasmussen B, Brinchmann-Hansen O, et al. Diabetic control and microvascular complications: the near normoglycemic experience. Diabetologia 29: 677–684, 1986

    Article  PubMed  CAS  Google Scholar 

  • Ingelfinger FJ. Debates on diabetes. New England Journal of Medicine 296: 1228–1230, 1977

    Article  PubMed  CAS  Google Scholar 

  • Ishihara M, Yukimura Y, Yamada T, Ohto K, Yoshizawa K. Diabetic complications and their relationships to risk factors in a Japanese population. Diabetes Care 7: 533–538, 1984

    Article  PubMed  CAS  Google Scholar 

  • Job D, Eschwege E, Guyo-Argenton C, Aubury JP, Tchobroutsky G. Effect of multiple daily insulin injections on the course of diabetic retinopathy. Diabetes 25: 463–469, 1976

    Article  Google Scholar 

  • Keiding NR, Root HF, Marble A. Importance of control of diabetes in prevention of vascular complications. Journal of the American Medical Association 150: 964–969, 1952

    Article  PubMed  CAS  Google Scholar 

  • Kimmelstiel P, Wilson C. Intercapillary lesions in glomeruli of kidney. American Journal of Pathology 12: 83, 1936

    PubMed  CAS  Google Scholar 

  • Kinoshita JH, Kador PF, Robinson G, Dalilis MB, Cobo LM,,et al. NIH conference: aldose reduction and complications of diabetes. Annals of Internal Medicine 101: 82, 1984

    PubMed  Google Scholar 

  • Klein BEK, Moss SE, Klein R. Longitudinal measure of glycemic control and diabetic retinopathy. Diabetes Care 10: 273–277, 1987

    Article  PubMed  CAS  Google Scholar 

  • Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. Retinopathy in young-onset diabetic patients. Diabetes Care 8: 311–315, 1985

    Article  PubMed  CAS  Google Scholar 

  • Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria: a preliminary multi-center trial. New England Journal of Medicine 311: 365–375, 1984

    Article  Google Scholar 

  • Kroc Collaborative Study Group. Diabetic retinopathy after two years of intensified insulin treatment. Journal of the American Medical Association 260: 37–41, 1988

    Article  Google Scholar 

  • Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T, the Steno Study Group. Effect of one year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet 1: 200–204, 1983

    Article  PubMed  CAS  Google Scholar 

  • Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T, the Steno Study Group. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 34 (Suppl. 3): 74–79, 1985

    PubMed  Google Scholar 

  • Lee CS, Mauer SM, Brown DM, Sutherland DER, Michael AF, et al. Renal transplantation in diabetes mellitus in rats. Journal of Experimental Medicine 139: 793, 1974

    Article  PubMed  CAS  Google Scholar 

  • Mannier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, et al. Relation between complications of Type I diabetes mellitus and collagen-linked fluorescence. New England Journal of Medicine 314: 403–408, 1986

    Article  Google Scholar 

  • Mauer SM, Stiffer MW, Sutherland DER, Najarian JS, Michael AF, et al. Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes 24: 280–285, 1975

    Article  PubMed  CAS  Google Scholar 

  • Mauer SM, Sutherland DER, Stiffer MW, Leonard RJ, Najarian JS, et al. Pancreatic islet transplantation: effects on the glomerular lesions of experimental diabetes in the rat. Diabetes 23: 748–753, 1974

    PubMed  CAS  Google Scholar 

  • Mecklenburg RS, Guinn TS, Sanner CA, Blumenstein BA. Malfunction of continuous subcutaneous insulin infusion systems: a one-year prospective study of 127 patients. Diabetes Care 9: 351–355, 1986

    Article  PubMed  CAS  Google Scholar 

  • Muhlhauser I. Near normoglycemia and microvascular complications. Diabetologia 30: 47–48, 1987

    Article  PubMed  CAS  Google Scholar 

  • Muhlhauser I, Bruckner I, Berger M, Chepta D, Jurgens V, et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of Type I (insulin-dependent) diabetes. Diabetologia 30: 681–690, 1987

    Article  PubMed  CAS  Google Scholar 

  • Paisey RB, Arredondo G, Villalobos A, Logano O, Guevara L, et al. Association of differing dietary, metabolic, and clinical risk factors with microvascular complications of diabetes: a prevalence study of 503 Mexican type II diabetic subjects. II. Diabetes Care 7: 428–433, 1984

    Article  CAS  Google Scholar 

  • Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1: 168–188; 252–263, 1978

    Google Scholar 

  • Ramsay RC, Goetz FC, Sutherland DER, Mauer SM, Robinson LL, et al. Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. New England Journal of Medicine 318: 208–214, 1988

    Article  PubMed  CAS  Google Scholar 

  • Schade DS, Santiago JV, Skyler JS, Rizza RA. Intensive insulin therapy, Excerpta Medica, 1983

  • Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, et al. Mean amplitude of glycemie excursions, a measure of diabetic instability. Diabetes 19: 644–655, 1970

    PubMed  CAS  Google Scholar 

  • Service FJ, Rizza RA, Daube JR, O’Brien PC, Dyck DJ. Near normoglycemia improved nerve conduction and vibration sensation in diabetic neuropathy. Diabetologia 28: 722–727, 1985

    PubMed  CAS  Google Scholar 

  • Siperstein MD, Foster DW, Knowles Jr JC, Levine R, Madison LL, et al. Control of blood glucose and diabetic vascular disease. New England Journal of Medicine 296: 1060–1063, 1977

    Article  PubMed  CAS  Google Scholar 

  • Siperstein MD, Unger RH, Madison LL. Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. Journal of Clinical Investigation 47: 1973–1999, 1968

    Article  PubMed  CAS  Google Scholar 

  • Solders G, Gunnarsson R, Persson A, Wilczek H, Tyden G, et al. Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two year follow-up study. Lancet 2: 1232–1235, 1987

    Article  PubMed  CAS  Google Scholar 

  • Steno Study Group. Effect of 6 months of strict metabolic control on eye and kidney function in insulin-dependent diabetics with background retinopathy. Lancet 1: 121–124, 1982

    Article  Google Scholar 

  • Sutherland DER, Kendall DM, Moudry KC, Navarro X, Kennedy WR, et al. Pancreas transplantation in nonuremic type I diabetic recipients. Surgery 104: 453–464, 1988

    PubMed  CAS  Google Scholar 

  • Tchobroutsky G. Relation of diabetic control to development of microvascular complications. Diabetologia 15: 143–152, 1978

    Article  PubMed  CAS  Google Scholar 

  • Teuscher A, Schnell H, Wilson PWF. Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care 11: 246–251, 1988

    Article  PubMed  CAS  Google Scholar 

  • Van der Vliet JA, Navarro X, Kennedy WR, Goetz FC, Najarian JS, et al. The effect of pancreas transplantation on diabetic polyneuropathy. Transplantation 45: 368–370, 1988

    Article  PubMed  Google Scholar 

  • Wagener HP, Dry TJS, Wilder RM. Retinitis in diabetes. New England Journal of Medicine 211: 1131–1137, 1934

    Article  Google Scholar 

  • Wilson JL, Root HF, Marble A. Prevention of degenerative vascular lesions in young patients by control of diabetes. American Journal of Medical Science 221: 479, 1951

    Article  CAS  Google Scholar 

  • Zimmerman BR. Aldose reductase inhibitors. In Dyck et al. (Eds) Diabetic neuropathy, pp. 190–193, WB Saunders Co, Pennsylvania, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Mayo Clinic, Rochester, Minnesota, 55905, USA

    Bruce R. Zimmerman

Authors
  1. Bruce R. Zimmerman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zimmerman, B.R. Influence of the Degree of Control of Diabetes on the Prevention, Postponement and Amelioration of Late Complications. Drugs 38, 941–956 (1989). https://doi.org/10.2165/00003495-198938060-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198938060-00006

Keywords

Search

Navigation